Herpes simplex keratitis is an eye infection affecting the cornea (the outer most protective layer at the front of the eye). It is an infection with herpes simplex virus, which is the same virus causing cold sores around the lips.
Herpes simplex keratitis causes an ulcer on the cornea. Most of the time, these ulcers can be treated easily with eye ointment. Rarely, herpes simplex keratitis can cause severe visual impairment, which occurs in approximately 1.5% of people who suffer from the condition .
This overview will cover the global problem of herpes simplex keratitis, its causes, common signs and symptoms, the categories of herpes simplex keratitis, how it progresses, how it is diagnosed, its treatment options, and whether it can be prevented.
Herpes simplex keratitis is a common eye condition. In developed countries, the incidence of herpes simplex keratitis is estimated to be 23.3 per 100,000 people per year . The incidence in developing countries is less well known but is considered to be at least as common as in developed nations.
From an economic perspective, it is estimated that in the United States, US$17.7 million is spent per year on the treatment of herpes simplex keratitis . There is likely to be additional economic impact associated with long term issues relating to herpes simplex keratitis, such as time off work and visual impairment.
Herpes simplex keratitis is a reactivation of the herpes simplex virus in the eye.
When herpes simplex virus infection occurs for the first time, it usually affects the skin on or around the lips, but can occur on the skin elsewhere on the face or on the skin around the eye. During this first infection, small blisters occur on the skin (known as ‘cold sores’ around the lips). These blisters can shed particles of virus which can be transmitted to others through contact.
Following this first infection, the virus remains dormant in the nerves supplying the skin of the face. From time to time, the virus will reactivate through these nerves. Most of the time, this reactivation presents with recurrence of cold sore blisters around the lips. In some people, the reactivation of the virus occurs in the eye, most commonly presenting as herpes simplex keratitis.
Following initial infection, the rates of recurrence of herpes simplex keratitis are estimated to be 10% at 1 year and up to 36% at 5 years .
Triggers for reactivation of herpes simplex virus may include:
The most common signs and symptoms of herpes simplex keratitis include:
If you experience any of these signs and symptoms, schedule an appointment with an eye health professional to get your eyes checked. It is also important to note that the development of eye conditions may even start before symptoms appear, which makes going for regular and timely eye checks that much more essential.
Herpes simplex keratitis can be categorised by which part of the eye it is affecting. Herpes simplex keratitis most commonly affects the outer layer of the cornea, the outer protective layer of the eye, and this is called epithelial keratitis.
In its more severe forms, it can affect the deeper structures of the cornea (called stromal keratitis) or cause inflammation in the eye (called keratouveitis).
Very rarely, herpes simplex virus can affect the retina which is a very severe form of herpetic eye disease (called retinitis or acute retinal necrosis).
In most cases, herpes simplex keratitis will respond well to treatment and should resolve within 1 to 3 weeks. The majority of people with herpes simplex keratitis will experience no change in their vision or a mild change in their vision .
A small proportion of patients will experience scarring of the cornea which significantly impacts the vision. Failing to treat herpes simplex keratitis may increase the risk of scarring and long-term issues with vision.
In a smaller proportion of people (estimated to be 2.6 per 100,000 people per year ), a more severe form of herpes simplex infection occurs whereby the deeper structures of the eye are affected. In these cases, the treatment is different and more prolonged and the risk of long-term visual impairment is higher.
Herpes simplex keratitis is diagnosed by an eye health professional based on a comprehensive eye check. The most important component of this is the slit lamp examination, where a microscope is used to look at the eye. An orange stain called fluorescein that produces a greenish-yellow fluorescence by reflected light is usually used to highlight the area of the ulcer.
Examination may also include looking at the back of the eye (the retina) and may involve dilating the pupils (making the pupils big) with eye drops
A swab of the cornea may be taken and sent for analysis to confirm the presence of herpes simplex virus.
In its mildest and most common form, herpes simplex keratitis affects only the outer layer of the cornea (the epithelium) and is treated with antiviral eye ointment. The medication used may vary but most commonly includes an antiviral medication called aciclovir.
In more severe forms, other medications may be used including steroid eye drops and oral antiviral medications in tablet form.
In cases where recurrences of herpes simplex keratitis are frequent, prophylactic oral antiviral medication may be prescribed and has been shown to be effective in reducing the risk of recurrence .
This may be particularly useful for people who have experienced more severe forms of herpes simplex keratitis where the risk of visual impairment is higher with recurrences. Other groups of people such as those with compromised immune systems may also benefit from prophylactic antiviral therapy.
Avoidance of the triggers described above may also assist in reducing the frequency of recurrences.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, include but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.
 Farooq, A. V. & Shukla, D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv. Ophthalmol. 57, 448–462 (2012).
 Lairson, D. R., Begley, C. E., Reynolds, T. F. & Wilhelmus, K. R. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch. Ophthalmol. 121, 108–112 (2003).
 Liesegang, T. J. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 107, 1160–1165 (1989).
 Wilhelmus, K. R., Coster, D. J., Donovan, H. C., Falcon, M. G. & Jones, B. R. Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration. Arch. Ophthalmol. 99, 1578–1582 (1981).
 Wilhelmus, K. R. et al. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N. Engl. J. Med. 339, 300–306 (1998).
Explore our specifically designed products and services backed by eye health professionals to help keep your children safe online and their eyes healthy.